Skip to content
Clinical Trials – home
BelgiumBack to Belgium

Clinical trials in Jette – page 33

2 047 clinical trials in Jette, Belgium across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Jette at a glance
2 047
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

2 047 trials in Jette

Open in trial search

Graves' disease

Recruiting

Study on the Effectiveness and Safety of IMVT-1402 for Adults with Graves' Disease

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Imeroprubart
  • Sponsor:Immunovant Sciences GmbH

Study on Long-Term Safety and Efficacy of VX-670 for Adults with Myotonic Dystrophy Type I

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:VX-670
  • Sponsor:Vertex Pharmaceuticals Inc.

Long-Term Safety Study of Inhaled Pirfenidone for Patients with Progressive or Idiopathic Pulmonary Fibrosis

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Pirfenidone
  • Sponsor:Avalyn Pharma Inc.

Hepatoblastoma+1

Recruiting

Study on the Safety and Effectiveness of Patritumab Deruxtecan for Children with Relapsed or Refractory Hepatoblastoma and Rhabdomyosarcoma

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Dexamethasone
  • Sponsor:Merck Sharp & Dohme LLC

Study on Doxycycline for Reducing Bacterial STIs in MSM and TGW with HIV

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Doxycycline Monohydrate
  • Sponsor:Institute Of Tropical Medicine

Study comparing NVL-655 to alectinib in untreated patients with ALK-positive advanced non-small cell lung cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:NVL-655
  • Sponsor:Nuvalent Inc.
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Colesevelam hydrochloride
  • Sponsor:Cosmo Technologies Limited

Study Comparing Sacituzumab Govitecan and Standard Treatment for Patients with Previously Treated Extensive Stage Small Cell Lung Cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Topotecan
  • Sponsor:Gilead Sciences Inc.

Study Comparing Rilvegostomig with Fluoropyrimidine and Trastuzumab Deruxtecan to Standard Treatment for Patients with HER2-positive Gastric Cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Astrazeneca AB

Study of Trastuzumab Deruxtecan and Rilvegostomig for Patients with Advanced HER2-positive Biliary Tract Cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Astrazeneca AB

Study on Rilzabrutinib for Patients Aged 10-65 with Sickle Cell Disease

Investigational
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years
  • Substances:Rilzabrutinib
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Ovarian cancer

Recruiting

Study Comparing Rinatabart Sesutecan with Other Treatments for Patients with Platinum-Resistant Ovarian Cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Glatiramer Acetate
  • Sponsor:Genmab A/S

Other cities in Belgium

The busiest research cities in the country

All 164 cities in Belgium

Clinical research in Jette

What the registry says about research in the country

01 Oncology Research

Clinical investigations focusing on innovative treatments for various cancers, including non-small cell lung cancer, melanoma, and colorectal cancer. Studies are evaluating new combination therapies and targeted treatments to improve patient outcomes.

  • Lung cancer therapeutics
  • Melanoma treatments
  • Pediatric liver tumors

Advanced clinical trials exploring immunotherapy combinations and targeted molecular approaches.

02 Metabolic Disorders

Research focusing on treatments for diabetes and obesity, including innovative therapies for both Type 1 and Type 2 diabetes. Studies are evaluating new medications for weight management and metabolic control.

  • Type 1 diabetes interventions
  • Obesity management
  • Weight maintenance in adolescents

Comprehensive trials investigating metabolic disease management and treatment outcomes.

03 Neurological Conditions

Studies examining treatments for status epilepticus and Alzheimer's-related psychosis. Research includes innovative approaches to managing neurological complications following cardiac arrest.

  • Post-cardiac arrest care
  • Alzheimer's disease complications
  • Seizure management

Advanced clinical research focusing on improving neurological outcomes and patient care.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.